Cargando…

Anti-tumor activity of silymarin nanoliposomes in combination with iron: In vitro and in vivo study

Combination therapy represents a promising strategy in cancer management by reducing chemotherapy resistance and associated side effects. Silymarin (SLM) has been extensively investigated due to its potent antioxidant properties and demonstrated efficacy against cancer cells. Under certain condition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doagooyan, Maham, Alavizadeh, Seyedeh Hoda, Sahebkar, Amirhossein, Houshangi, Kebria, Khoddamipour, Zahra, Gheybi, Fatemeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660084/ https://www.ncbi.nlm.nih.gov/pubmed/38024450 http://dx.doi.org/10.1016/j.ijpx.2023.100214

Ejemplares similares

Harnessing aptamers against COVID-19: A therapeutic strategy
por: Mahmoudi, Ali, et al.
Publicado: (2023)

Antisense technology as a potential strategy for the treatment of coronaviruses infection: With focus on COVID‐19
por: Alavizadeh, Seyedeh Hoda, et al.
Publicado: (2022)

In-vitro and In-vivo Evaluation of Silymarin Nanoliposomes against Isolated Methicillin-resistant Staphylococcus aureus
por: Faezizadeh, Zohreh, et al.
Publicado: (2015)

Novel nanomicelle formulation to enhance bioavailability and stability of curcuminoids
por: Hatamipour, Mahdi, et al.
Publicado: (2019)

Preparation, characterization, and biodistribution of glutathione PEGylated nanoliposomal doxorubicin for brain drug delivery with a post-insertion approach
por: Mehrabian, Amin, et al.
Publicado: (2022)

In Vitro and In Vivo Anti-Aging Effect of Coffee Berry Nanoliposomes
por: Saewan, Nisakorn, et al.
Publicado: (2023)

Potential anti-tumor effect of a nanoliposomal antiPCSK9 vaccine in mice bearing colorectal cancer
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019)

Pre-Clinical Evaluation of the Nanoliposomal antiPCSK9 Vaccine in Healthy Non-Human Primates
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2021)

Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2019)

PCSK9 immunization using nanoliposomes: preventive efficacy against hypercholesterolemia and atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2021)

Synthesis, characterization and hepatoprotective effect of silymarin phytosome nanoparticles on ethanol-induced hepatotoxicity in rats
por: Gohari Mahmoudabad, Arezoo, et al.
Publicado: (2023)

Retraction Note: Therapeutic effect of nanoliposomal PCSK9 vaccine in a mouse model of atherosclerosis
por: Momtazi-Borojeni, Amir Abbas, et al.
Publicado: (2023)

In vitro and in vivo study of a nanoliposomal cisplatin as a radiosensitizer
por: Zhang, Xiaomeng, et al.
Publicado: (2011)

Protective Role of Silymarin and Deferoxamine Against Iron Dextran-induced Renal Iron Deposition in Male Rats
por: Nematbakhsh, Mehdi, et al.
Publicado: (2013)

Targeting brain cells with glutathione-modulated nanoliposomes: in vitro and in vivo study
por: Salem, Heba F, et al.
Publicado: (2015)

Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model
por: Navidi-Shishaone, Mitra, et al.
Publicado: (2014)

Mannosylated-Chitosan-Coated Andrographolide Nanoliposomes for the Treatment of Hepatitis: In Vitro and In Vivo Evaluations
por: Metkar, Sayali Pravin, et al.
Publicado: (2023)

Preparation and Evaluation of Silymarin-Loaded Solid Eutectic for Enhanced Anti-Inflammatory, Hepatoprotective Effect: In Vitro–In Vivo Prospect
por: Sherikar, Abdulla, et al.
Publicado: (2021)

Development of a nanoliposomal formulation of erlotinib for lung cancer and in vitro/in vivo antitumoral evaluation
por: Zhou, Xiao, et al.
Publicado: (2017)

Development of a Nanoliposomal Formulation of Erlotinib for Lung Cancer and in vitro/In vivo Antitumoral Evaluation [Retraction]
Publicado: (2022)

Nanoliposomal Nitroglycerin Exerts Potent Anti-Inflammatory Effects
por: Ardekani, Soroush, et al.
Publicado: (2015)

Analytical methods for investigating in vivo fate of nanoliposomes: A review
por: Su, Chong, et al.
Publicado: (2018)

Tea tree oil nanoliposomes: optimization, characterization, and antibacterial activity against Escherichia coli in vitro and in vivo
por: Bo, RuoNan, et al.
Publicado: (2022)

Differential regulation of CD4(+) T cell subsets by Silymarin in vitro and in ovalbumin immunized mice
por: Namdari, Haideh, et al.
Publicado: (2018)

Re: “Protective Role of Silymarin and Deferoxamine against Iron Dextran-Induced Renal Iron Deposition in Male Rats,” and “Co-Administration of Silymarin and Deferoxamine against Kidney, Liver and Heart Iron Deposition in Male Iron Overload Rat Model”
por: Mazaheri, Safoora, et al.
Publicado: (2014)

Nanoliposomes as Vehicles for Astaxanthin: Characterization, In Vitro Release Evaluation and Structure
por: Pan, Li, et al.
Publicado: (2018)

Dehydroflavonolignans from Silymarin Potentiate Transition Metal Toxicity In Vitro but Are Protective for Isolated Erythrocytes Ex Vivo
por: Lomozová, Zuzana, et al.
Publicado: (2021)

In vitro and in vivo activities of ticarcillin-loaded nanoliposomes with different surface charges against Pseudomonas aeruginosa (ATCC 29248)
por: Gharib, Amir, et al.
Publicado: (2012)

Novel nanoliposomal delivery system for polydatin: preparation, characterization, and in vivo evaluation
por: Wang, Xiaobo, et al.
Publicado: (2015)

In Vitro Antimicrobial and Modulatory Activity of the Natural Products Silymarin and Silibinin
por: Rakelly de Oliveira, Dayanne, et al.
Publicado: (2015)

Silymarin and diabetic nephropathy
por: Rafieian-Kopaie, Mahmoud, et al.
Publicado: (2012)

Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing
por: Ullah, Hammad, et al.
Publicado: (2018)

Proliferative and Anti-Inflammatory Effects of Resveratrol and Silymarin on Human Gingival Fibroblasts: A View to the Future
por: Shahidi, Minoo, et al.
Publicado: (2017)

Re: Protective Role of Silymarin and Deferoxamine against Iron Dextran - Induced Renal Iron Deposition in Male Rats
por: Baradaran, Azar, et al.
Publicado: (2014)

Comment on: The Protective Role of Silymarin and Deferoxamine Against Iron Dextran-Induced Renal Iron Deposition in Male Rats
por: Baradaran, Azar
Publicado: (2013)

Effects of Silymarin on the In Vivo Pharmacokinetics of Simvastatin and Its Active Metabolite in Rats
por: Li, Ying, et al.
Publicado: (2019)

Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin
por: Gharib, Amir, et al.
Publicado: (2014)

Anabolic Peptide-Enriched Stealth Nanoliposomes for Effective Anti-Osteoporotic Therapy
por: Salave, Sagar, et al.
Publicado: (2022)

Therapeutic Value of Combined Therapy with Deferasirox and Silymarin on Iron Overload in Children with Beta Thalassemia
por: Hagag, Adel A., et al.
Publicado: (2013)

Therapeutic potential of silymarin as a natural iron‐chelating agent in β‐thalassemia intermedia
por: Reisi, Nahid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ac66bsnj1pa9b6q992m3l4rgml